Study: Sickle cell anemia treatment does not increase malaria risk in Africa

The drug hydroxyurea does not appear to increase the risk of malaria infection in patients with sickle cell anemia who live in malaria-endemic regions, according to a study published online today in Blood, a Journal of the American Society of Hematology (ASH).

IU awarded $7.6 million grant to establish groundbreaking study of early-onset Alzheimer’s disease

Indiana University School of Medicine has been awarded a one-year, $7.6 million grant from the National Institute on Aging (NIA) to establish a network of sites to study early-onset Alzheimer’s disease.

IU Adolescent Health Researchers Selected for National Leadership Program to Build Health Equity

The ability to design targeted research to meet urgent community needs, followed by its direct implementation, researchers and community leaders are powerful partners in instilling change to meet regional health care needs.

Bart Peterson to lead IU Center for Global Health/AMPATH development board

Breast cancer experts available from IU School of Medicine to speak with media

In preparation for Breast Cancer Awareness month, five expert faculty surgeons and researchers from the IU School of Medicine Department of Surgery are available to discuss breast cancer, breast disease, current research initiatives at IU School of Medicine, and best surgical practice and treatment for breast cancer patients.

IU School of Medicine awarded prestigious $2.1 million grant to study traumatic brain injury

Indiana University School of Medicine, in partnership with the Rehabilitation Hospital of Indiana, has been awarded a $2.1 million grant to study traumatic brain injury over five years as one of 16 National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) Traumatic Brain Injury Model Systems sites in the country.

IU, Regenstrief, LifeOmic announce collaboration to revolutionize medicine

Indiana University, the Regenstrief Institute and Indianapolis-based technology company LifeOmic have announced a first-of-its-kind collaboration to advance the development of precision medicine, a personalized approach to disease treatment and prevention.

Overall cancer risk not increased with use of popular diabetes medication, IU study finds

People taking a new oral medication for Type 2 diabetes can breathe a sigh of relief concerning suspicions they might be at an increased risk for many types of cancer, according to Indiana University researchers.